Avalere Forms New Partnership With Michael Waitzkin from Catawba Consulting
Summary
Avalere is pleased to announce a new formalized collaboration with Michael “Buz” Waitzkin.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
Buz will work with Avalere on strategic regulatory assessments and other due diligence projects, specifically assisting clients in evaluating potential acquisition and in-licensing targets across all sub-sectors of the life sciences industry.
Buz brings almost 40 years of regulatory and legal experience to the FDA Regulatory Policy and Strategy team, with previous work experiences spanning from special counsel to President Clinton to private practice, with a focus on biomedical research.
Related Content
